Email

Erin.Peckham-Gregory@bcm.edu

Positions

Assistant Professor

Pediatrics
Hematology-Oncology
Baylor College of Medicine
Houston, TX US

Education

Postdoctoral Fellowship at Baylor College of Medicine

06/2017 - Houston, Texas United States

NCI-funded R25T fellowship program in Pediatric Cancer Epidemiology and Control

PhD from University of California at Los Angeles

09/2014 - Los Angeles, California United States

Cancer Epidemiology

MPH from University of California at Los Angeles

06/2009 - Los Angeles, California United States

Epidemiology

BS from University of California at Los Angeles

06/2007 - Los Angeles, California United States

Ecology and Evolutionary Biology

Professional Statement

Research Focus: I am a molecular epidemiologist whose primary research focus is to elucidate inherited genetic effects and epidemiologic factors underlying susceptibility to pediatric lymphoproliferative and HIV-related malignancies. I have developed local, national and global collaborations with experts in the fields of Langerhans cell histiocytosis (LCH) and lymphoma to assess epidemiologic and genetic predictors of these pediatric cancers. The resulting studies are designed to better understand the molecular underpinnings of these malignancies through an integrated approach. To assess the multifactorial aspects of pediatric HIV-related malignancies, I have ongoing collaborations with members of the Global Hematology-Oncology Pediatric Excellence Program and Baylor International Pediatric AIDS Initiative at Texas Children’s Hospital. A secondary focus is to evaluate racial/ethnic disparities and the impact of genomic ancestry on susceptibility to pediatric cancer and subsequent adverse events.

Websites

Selected Publications

• Peckham-Gregory EC, Chakraborty R, Scheurer ME, Belmont JW, Abhyankar H, Sengal AG, Scull BP, Eckstein OE, Zinn DJ, Mayer L, Shih A, Merad M, Parsons DW, McClain KL, Lupo PJ, Allen CE "A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility." Blood. 2017;130(20):2229-2232. Pubmed PMID: 28935696
• Peckham-Gregory EC, McClain KL, Allen CE, Scheurer ME, Lupo PJ "The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among Hispanics." Ann Epidemiol. 2018;28(8):521-528. Pubmed PMID: 29724524
• Eckstein OS, Visser J, Rodriguez-Galindo C, Allen CE; NACHO-LIBRE Study Group: Zinn DJ, Peckham-Gregory EC, Lin H, Henry MM, Morland B, Fein Levy C, Kumar A, Schiff D, Karras N, Chu RL, Abla O, Hijiya N, Kim SY, Campbell PK, Woods-Swafford, et. al. "Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition." Blood. 2019;133(15):1691-1694. Pubmed PMID: 30718231
• Chinn IK, Eckstein OS, Peckham-Gregory EC, Goldberg BR, Forbes LR, Nicholas SK, Mace EM, Vogel TP, Abhyankar HA, Diaz MI, Heslop HE, Krance RA, Martinez CA, Nguyen TC, Bashir DA, Goldman JR, Stray-Pedersen A, Pedroza LA, Poli MC, et. al "Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis." Blood. 2018;132(1):89-100. Pubmed PMID: 29632024

Memberships

Children's Oncology Group

Hodgkin Lymphoma Committee Member (09/2018)

International Society of Pediatric Oncology

Young Investigator Network Board Member (11/2019)

International Lymphoma Epidemiology Consortium

Member (06/2014)

American Society of Hematology

Member (11/2017)

Histiocyte Society

Member (09/2016)